A new study finds that a single dose of the mpox vaccine offers 58 per cent protection against the virus, providing promising evidence for its effectiveness in real-world settings.
A new study finds that a single dose of the mpox vaccine offers 58 per cent protection against the virus, providing promising evidence for its effectiveness in real-world settings.